Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

aehr test systems - AEHR

AEHR

Close Chg Chg %
76.27 9.99 13.10%

Closed Market

86.26

+9.99 (13.10%)

Volume: 4.52M

Last Updated:

Sep 4, 2026, 4:00 PM EDT

Trade Now

Company Overview: aehr test systems - AEHR

AEHR Key Data

Open

$78.55

 Day Range

77.84 - 86.67

52 Week Range

18.70 - 147.40

 Market Cap

$2.62B

Shares Outstanding

32.62M

 Public Float

30.99M

Beta

3.07

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.24

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

2.57M

  

AEHR Performance

1 Week
 
 6.74%
 
1 Month
 
 -16.31%
 
3 Months
 
 -12.38%
 
1 Year
 
 237.48%
 
5 Years
 
 928.13%
 

AEHR Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 6
Full Ratings ➔

About aehr test systems - AEHR

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

AEHR At a Glance

Aehr Test Systems
400 Kato Terrace
Fremont, California 94539
Phone 1-510-623-9400 Revenue 50.00M
Industry Electronic Production Equipment Net Income -7,126,000.00
Sector Electronic Technology Employees 138
Fiscal Year-end 05 / 2027
View SEC Filings

AEHR Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 56.632
Price to Book Ratio 13.662
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -256.779
Enterprise Value to Sales 54.503
Total Debt to Enterprise Value 0.004

AEHR Efficiency

Revenue/Employee 362,326.087
Income Per Employee -51,637.681
Receivables Turnover 2.581
Total Asset Turnover 0.253

AEHR Liquidity

Current Ratio 10.33
Quick Ratio 8.014
Cash Ratio 6.517

AEHR Profitability

Gross Margin 35.301
Operating Margin -28.285
Pretax Margin -23.472
Net Margin -14.252
Return on Assets -3.606
Return on Equity -4.163
Return on Total Capital -3.106
Return on Invested Capital -3.942

AEHR Capital Structure

Total Debt to Total Equity 4.502
Total Debt to Total Capital 4.308
Total Debt to Total Assets 4.006
Long-Term Debt to Equity 4.217
Long-Term Debt to Total Capital 4.035
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Aehr Test Systems - AEHR

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
64.96M 66.22M 58.97M 50.00M
Sales Growth
+27.80% +1.94% -10.95% -15.21%
Cost of Goods Sold (COGS) incl D&A
32.22M 33.67M 35.03M 32.35M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
450.00K 1.36M 3.39M 3.53M
Depreciation
450.00K 1.36M 2.19M 2.33M
Amortization of Intangibles
- - 1.20M 1.20M
-
COGS Growth
+18.59% +4.53% +4.04% -7.66%
Gross Income
32.75M 32.54M 23.93M 17.65M
Gross Income Growth
+38.37% -0.62% -26.46% -26.25%
Gross Profit Margin
+50.41% +49.15% +40.59% +35.30%
2023 2024 2025 2026 5-year trend
SG&A Expense
19.37M 22.46M 28.25M 31.79M
Research & Development
7.13M 8.72M 10.46M 12.63M
Other SG&A
12.24M 13.75M 17.78M 19.16M
SGA Growth
+22.10% +15.97% +25.73% +12.56%
Other Operating Expense
- - - -
-
Unusual Expense
- - 1.36M 6.00K
-
EBIT after Unusual Expense
13.38M 10.08M (5.68M) (14.15M)
Non Operating Income/Expense
1.24M 2.38M 1.39M 2.41M
Non-Operating Interest Income
1.25M 2.39M 1.40M 1.36M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
14.62M 12.46M (4.29M) (11.74M)
Pretax Income Growth
+53.20% -14.77% -134.44% -173.50%
Pretax Margin
+22.50% +18.81% -7.28% -23.47%
Income Tax
60.00K (20.70M) (381.00K) (4.61M)
Income Tax - Current - Domestic
- 28.00K 20.00K 7.00K
Income Tax - Current - Foreign
32.00K 55.00K 33.00K 105.00K
Income Tax - Deferred - Domestic
- (20.77M) (421.00K) (4.71M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
14.56M 33.16M (3.91M) (7.13M)
Minority Interest Expense
- - - -
-
Net Income
14.56M 33.16M (3.91M) (7.13M)
Net Income Growth
+54.04% +127.77% -111.79% -82.25%
Net Margin Growth
+22.41% +50.07% -6.63% -14.25%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
14.56M 33.16M (3.91M) (7.13M)
Preferred Dividends
- - - -
-
Net Income Available to Common
14.56M 33.16M (3.91M) (7.13M)
EPS (Basic)
0.5239 1.1505 -0.1322 -0.2324
EPS (Basic) Growth
+44.21% +119.60% -111.49% -75.79%
Basic Shares Outstanding
27.79M 28.82M 29.58M 30.67M
EPS (Diluted)
0.4983 1.1195 -0.1322 -0.2324
EPS (Diluted) Growth
+46.47% +124.66% -111.81% -75.79%
Diluted Shares Outstanding
29.21M 29.62M 29.58M 30.67M
EBITDA
13.82M 11.44M (925.00K) (10.61M)
EBITDA Growth
+70.53% -17.24% -108.08% -1,047.35%
EBITDA Margin
+21.28% +17.28% -1.57% -21.23%

Snapshot

Average Recommendation BUY Average Target Price 127.00
Number of Ratings 6 Current Quarters Estimate 0.108
FY Report Date 06 / 2027 Current Year's Estimate 0.758
Last Quarter’s Earnings 0.11 Median PE on CY Estimate N/A
Year Ago Earnings 0.03 Next Fiscal Year Estimate 1.40
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 5 1 5 4
Mean Estimate 0.11 0.27 0.76 1.40
High Estimates 0.13 0.27 0.80 1.54
Low Estimate 0.07 0.27 0.70 1.13
Coefficient of Variance 23.06 N/A 5.14 13.13

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 6 6 3
OVERWEIGHT 0 0 1
HOLD 0 0 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Aehr Test Systems - AEHR

Date Name Shares Transaction Value
Aug 19, 2026 Vernon Rogers Exec VP of Sales & Mktg. 186,232 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $143.77 per share 26,774,574.64
Aug 19, 2026 Vernon Rogers Exec VP of Sales & Mktg. 190,226 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $139 per share 26,441,414.00
Aug 19, 2026 Vernon Rogers Exec VP of Sales & Mktg. 191,226 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $134 per share 25,624,284.00
Jun 23, 2026 Laura Oliphant Director; Director 16,697 Bona fide gift 0.00
Jun 23, 2026 Laura Oliphant Director; Director 16,678 Bona fide gift 0.00
Jun 23, 2026 Laura Oliphant Director; Director 16,659 Bona fide gift 0.00
Jun 5, 2026 Didier Wimmers Executive VP of R&D 10,327 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $114.59 per share 1,183,370.93
Apr 21, 2026 Rhea J. Posedel Director; Director 396,979 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $88.09 per share 34,969,880.11
Apr 21, 2026 Alistair N Sporck VP Contactor Business Unit 20,294 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $83.86 per share 1,701,854.84
Apr 16, 2026 Geoffrey G. Scott Director 100,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $67.79 per share 6,779,000.00
Apr 16, 2026 Geoffrey G. Scott Director 110,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $68.12 per share 7,493,200.00
Apr 16, 2026 Geoffrey G. Scott Director 135,000 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $68 per share 9,180,000.00
Apr 16, 2026 Didier Wimmers Executive VP of R&D 10,659 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $72.02 per share 767,661.18
Apr 16, 2026 Donald P. Richmond CTO 181,512 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $73.18 per share 13,283,048.16
Apr 15, 2026 Adil Engineer Chief Operating Officer 42,641 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $66.32 per share 2,827,951.12
Apr 15, 2026 Donald P. Richmond CTO 198,523 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $74.38 per share 14,766,140.74
Apr 15, 2026 Alistair N Sporck VP Contactor Business Unit 22,635 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 1,594,183.05
Apr 15, 2026 Christopher P. Siu CFO 70,740 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 4,982,218.20
Apr 15, 2026 Gayn Erickson President and CEO; Director 197,723 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $70.58 per share 13,955,289.34
Apr 15, 2026 Gayn Erickson President and CEO; Director 188,295 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $70.43 per share 13,261,616.85

Aehr Test Systems in the News